|
1
|
Wang JB, Wang Y, Li LY, Cai SQ, Mao DD, Lou HK and Zhao J: Network pharmacology-based pharmacological mechanism prediction of Lycii Fructus against postmenopausal osteoporosis. Medicine (Baltimore). 102(e36292)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Iantomasi T, Romagnoli C, Palmini G, Donati S, Falsetti I, Miglietta F, Aurilia C, Marini F, Giusti F and Brandi ML: Oxidative stress and inflammation in osteoporosis: Molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci. 24(3772)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
An HQ, Chu C, Zhang Z, Zhang YH, Wei R, Wang B, Xu K, Li LH, Liu Y, Li G and Li X: Hyperoside alleviates postmenopausal osteoporosis via regulating miR-19a-5p/IL-17A axis. Am J Reprod Immunol. 90(e13709)2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Noh JY, Yang Y and Jung HY: Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci. 21(7623)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhou D, Zhang H, Xue X, Tao Y, Wang S, Ren X and Su J: Safety evaluation of natural drugs in chronic skeletal disorders: A literature review of clinical trials in the past 20 years. Front Pharmacol. 12(801287)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gu Y, Chen X, Wang Y, Liu Y, Zheng L, Li X, Wang R, Wang S, Li S, Chai Y, et al: Development of 3-mercaptopropyltrimethoxysilane (MPTS)-modified bone marrow mononuclear cell membrane chromatography for screening anti-osteoporosis components from Scutellariae Radix. Acta Pharm Sin B. 10:1856–1865. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yuan J, Maturavongsadit P, Zhou Z, Lv B, Lin Y, Yang J and Luckanagul JA: Hyaluronic acid-based hydrogels with tobacco mosaic virus containing cell adhesive peptide induce bone repair in normal and osteoporotic rats. Biomater Transl. 1:89–98. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Xu X, Zhang Z, Wang W, Yao H and Ma X: Therapeutic effect of cistanoside A on bone metabolism of ovariectomized mice. Molecules. 22(197)2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Huang J, Zhang Y, Dong L, Gao Q, Yin L, Quan H, Chen R, Fu X and Lin D: Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis Sieb. et Zucc. J Ethnopharmacol. 1213:280–301. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kim JY, Kim YK, Choi MK, Oh J, Kwak HB and Kim JJ: Effect of cornus officinalis on receptor activator of nuclear Factor-kappaB Ligand (RANKL)-induced Osteoclast Differentiation. J Bone Metab. 19:121–127. 2012.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu S, Shen H, Li J, Gong Y, Bao H, Zhang J, Hu L, Wang Z and Gong J: Loganin inhibits macrophage M1 polarization and modulates sirt1/NF-κB signaling pathway to attenuate ulcerative colitis. Bioengineered. 11:628–639. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li M, Wang W, Wang P, Yang K, Sun H and Wang X: The pharmacological effects of morroniside and loganin isolated from Liuweidihuang Wan, on MC3T3-E1 cells. Molecules. 15:7403–7314. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xia H, Liu J, Yang W, Liu M, Luo Y, Yang Z, Xie J, Zeng H, Xu R, Ling H, et al: Integrated strategy of network pharmacological prediction and experimental validation elucidate possible mechanism of Bu-Yang Herbs in treating postmenopausal osteoporosis via ESR1. Front Pharmacol. 12(654714)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bai X, Tang Y, Li Q, Chen Y, Liu D, Liu G, Fan X, Ma R, Wang S, Li L, et al: Network pharmacology integrated molecular docking reveals the bioactive components and potential targets of Morinda officinalis-Lycium barbarum coupled-herbs against oligoasthenozoospermia. Sci Rep. 11(2220)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen X, Wang J, Tang L, Ye Q, Dong Q, Li Z, Hu L, Ma C, Xu J and Sun P: The therapeutic effect of Fufang Zhenshu Tiaozhi (FTZ) on osteoclastogenesis and ovariectomized-induced bone loss: Evidence from network pharmacology, molecular docking and experimental validation. Aging (Albany NY). 14:5727–5748. 2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kong Y, Ma X, Zhang X, Wu L, Chen D, Su B, Liu D and Wang X: The potential mechanism of Fructus Ligustri Lucidi promoting osteogenetic differentiation of bone marrow mesenchymal stem cells based on network pharmacology, molecular docking and experimental identification. Bioengineered. 13:10640–10653. 2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang H, Zhou C, Zhang Z, Yao S, Bian Y, Fu F, Luo H, Li Y, Yan S, Ge Y, et al: Integration of Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanisms of Zhuanggu Busui Formula Against Osteoporosis. Front Endocrinol (Lausanne). 12(841668)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Huang J, Wang X, Zheng J, Jia Q, Wang X, Xie Z and Ma H: Mechanisms underlying the therapeutic effects of isoflavones isolated from chickpea sprouts in treating osteoporosis based on network pharmacology. Biochem Biophys Res Commun. 671:26–37. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Park E, Lee CG, Yun SH, Hwang S, Jeon H, Kim J, Yeo S, Jeong H, Yun SH and Jeong SY: Ameliorative effects of loganin on arthritis in chondrocytes and destabilization of the medial meniscus-induced animal model. Pharmaceuticals (Basel). 14(135)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals. In: The National Academies Collection: Reports funded by National Institutes of Health. 8th edition. National Academy of Sciences (US), Washington, DC, 2011.
|
|
21
|
Xiao J, Shang W and Zhao Z, Jiang J, Chen J, Cai H, He J, Cai Z and Zhao Z: Pharmacodynamic material basis and potential mechanism study of spatholobi caulis in reversing osteoporosis. Evid Based Complement Alternat Med. 2023(3071147)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu Y, He Y, He B and Kong L: The Anti-osteoporosis Effects of Vitamin K in postmenopausal women. Curr Stem Cell Res Ther. 2:186–192. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee CG, Kim DW, Kim J, Uprety LP, Oh KI, Singh S, Yoo J, Jin HS, Choi TH, Park E and Jeong SY: Effects of loganin on bone formation and resorption in vitro and in vivo. Int J Mol Sci. 23(14128)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Isken I, Witayateeraporn W, Wirojwongchai T, Suraphan C, Pornputtapong N, Singharajkomron N, Nguyen HM and Pongrakhananon V: Identifying molecular targets of Aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments. Sci Rep. 13(1545)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhu M, Guo Q, Kang H, Peng R, Dong Y, Zhang Y, Wang S, Liu H, Zhao H, Dong Z, et al: Inhibition of FAAH suppresses RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss partially through repressing the IL17 pathway. FASEB J. 37(e22690)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Scheffler JM, Grahnemo L, Engdahl C, Drevinge C, Gustafsson KL, Corciulo C, Lawenius L, Iwakura Y, Sjögren K, Lagerquist MK, et al: Interleukin 17A: A Janus-faced regulator of osteoporosis. Sci Rep. 10(5692)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wu Y, Yang Y, Wang L, Chen Y, Han X, Sun L, Chen H and Chen Q: Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism. Front Endocrinol (Lausanne). 14(1109296)2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hu J, Zhou J, Wu J, Chen Q, Du W, Fu F, Yu H, Yao S, Jin H, Tong P, et al: Loganin ameliorates cartilage degeneration and osteoarthritis development in an osteoarthritis mouse model through inhibition of NF-κB activity and pyroptosis in chondrocytes. J Ethnopharmacol. 247(112261)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Brigati C, Banelli B, di Vinci A, Casciano I, Allemanni G, Forlani A, Borzì L and Romani M: Inflammation, HIF-1, and the epigenetics that follows. Mediators Inflamm. 2010(263914)2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhao J, Lin F, Liang G, Han Y, Xu N, Pan J, Luo M, Yang W and Zeng L: Exploration of the molecular mechanism of polygonati rhizoma in the treatment of osteoporosis based on network pharmacology and molecular docking. Front Endocrinol (Lausanne). 12(815891)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Xue C, Luo H, Wang L, Deng Q, Kui W, Da W, Chen L, Liu S, Xue Y, Yang J, et al: Aconine attenuates osteoclast-mediated bone resorption and ferroptosis to improve osteoporosis via inhibiting NF-κB signaling. Front Endocrinol (Lausanne). 14(1234563)2023.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Al-Daghri NM, Aziz I, Yakout S, Aljohani NJ, Al-Saleh Y, Amer OE, Sheshah E, Younis GZ and Al-Badr FBM: Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis. Medicine (Baltimore). 96(e5780)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mentzel J, Kynast T, Kohlmann J, Kirsten H, Blüher M, Simon JC, Kunz M and Saalbach A: Reduced serum levels of bone formation marker P1NP in psoriasis. Front Med (Lausanne). 8(730164)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sapra L, Bhardwaj A, Mishra PK, Garg B, Verma B, Mishra GC and Srivastava RK: Regulatory B Cells (Bregs) inhibit osteoclastogenesis and play a potential role in ameliorating ovariectomy-induced bone loss. Front Immunol. 12(691081)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jung YK, Kang YM and Han S: Osteoclasts in the inflammatory arthritis: Implications for pathologic osteolysis. Immune Netw. 19(e2)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, et al: Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med. 191:275–286. 2000.PubMed/NCBI View Article : Google Scholar
|
|
37
|
O'Brien W, Fissel BM, Maeda Y, Yan J, Ge X, Gravallese EM, Aliprantis AO and Charles JF: RANK-Independent osteoclast formation and bone erosion in inflammatory arthritis. Arthritis Rheumatol. 68:2889–2900. 2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Axmann R, Böhm C, Krönke G, Zwerina J, Smolen J and Schett G: Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum. 60:2747–2756. 2009.PubMed/NCBI View Article : Google Scholar
|
